Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

China Molybdenum Co Invests in High-Growth Sectors through Boyu Capital Fund

Tipranks - Tue Dec 9, 2025

TipRanks Cyber Monday Sale

China Molybdenum Co ( (HK:3993) ) has issued an announcement.

China Molybdenum Co, through its wholly-owned subsidiary Xizang Shmok, has invested RMB500 million in a limited partnership fund managed by Boyu Capital. This fund aims to achieve favorable capital returns by focusing on high-growth sectors such as technology, healthcare, and consumer products. The investment will be accounted for as financial assets at fair value through profit or loss, reflecting the company’s strategic move to leverage idle cash for potential growth opportunities in these sectors.

The most recent analyst rating on (HK:3993) stock is a Buy with a HK$21.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.

More about China Molybdenum Co

YTD Price Performance: 276.31%

Average Trading Volume: 50,359,306

Technical Sentiment Signal: Buy

Current Market Cap: HK$428.9B

Find detailed analytics on 3993 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.